Aliases & Classifications for Atherosclerosis

MalaCards integrated aliases for Atherosclerosis:

Name: Atherosclerosis 38 12 29 52 41 42 14 69
Arteriosclerosis 69

Classifications:



External Ids:

Disease Ontology 12 DOID:1936
ICD10 33 I25.1 I70
ICD9CM 35 440
MeSH 42 D050197
UMLS 69 C0004153

Summaries for Atherosclerosis

MedlinePlus : 41 atherosclerosis is a disease in which plaque builds up inside your arteries. plaque is a sticky substance made up of fat, cholesterol, calcium, and other substances found in the blood. over time, plaque hardens and narrows your arteries. that limits the flow of oxygen-rich blood to your body. atherosclerosis can lead to serious problems, including coronary artery disease. these arteries supply blood to your heart. when they are blocked, you can suffer angina or a heart attack. carotid artery disease. these arteries supply blood to your brain. when they are blocked you can suffer a stroke. peripheral arterial disease. these arteries are in your arms, legs and pelvis. when they are blocked, you can suffer from numbness, pain and sometimes infections. atherosclerosis usually doesn't cause symptoms until it severely narrows or totally blocks an artery. many people don't know they have it until they have a medical emergency. a physical exam, imaging, and other diagnostic tests can tell if you have it. medicines can slow the progress of plaque buildup. your doctor may also recommend procedures such as angioplasty to open the arteries, or surgery on the coronary or carotid arteries. lifestyle changes can also help. these include following a healthy diet, getting regular exercise, maintaining a healthy weight, quitting smoking, and managing stress. nih: national heart, lung, and blood institute

MalaCards based summary : Atherosclerosis, also known as arteriosclerosis, is related to arthritis and angina pectoris, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Atherosclerosis is SELE (Selectin E), and among its related pathways/superpathways are Blood-Brain Barrier and Immune Cell Transmigration: VCAM-1/CD106 Signaling Pathways and Lipoprotein metabolism. The drugs Olmesartan and Aspirin have been mentioned in the context of this disorder. Affiliated tissues include Endothelium and Heart, and related phenotypes are Decreased free cholesterol and cardiovascular system

Wikipedia : 72 Atherosclerosis (also known as arteriosclerotic vascular disease or ASVD) is a specific form of... more...

Related Diseases for Atherosclerosis

Diseases related to Atherosclerosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 441)
id Related Disease Score Top Affiliating Genes
1 arthritis 31.7 ABCG8 APOE LDLR LPA
2 angina pectoris 31.1 LPA SELE VCAM1 VEGFA
3 rheumatoid arthritis 31.0 CCL2 ICAM1 TNF VCAM1 VEGFA
4 systemic lupus erythematosus 30.5 CCL2 ICAM1 SELE TNF VCAM1
5 alopecia 30.5 CCL2 ICAM1 TNF
6 renovascular hypertension 30.3 EDN1 NOS3 VCAM1
7 asthma 30.1 EDN1 ICAM1 MMP9 SELE TNF VCAM1
8 calcinosis 30.1 CCL2 EDN1 TNF
9 peripheral artery disease 29.7 ABCG8 APOE CCL2 EDN1 ICAM1 LDLR
10 myocardial infarction 29.4 APOE CCL2 EDN1 HMGCR ICAM1 LDLR
11 cerebral atherosclerosis 12.3
12 aortic atherosclerosis 12.2
13 generalized atherosclerosis 12.1
14 atherosclerosis, premature, with deafness, nephropathy, diabetes mellitus, photomyoclonus, and degenerative neurologic disease 11.8
15 feigenbaum bergeron richardson syndrome 11.4
16 renal artery atheroma 11.3
17 arteriosclerosis 11.2
18 sitosterolemia 11.2
19 peripheral vascular disease 11.1
20 binswanger's disease 11.1
21 werner syndrome 11.1
22 cerebrotendinous xanthomatosis 11.1
23 coronary artery disease 11.1
24 cataract, autosomal dominant congenital 4 11.1 APOE PPARG SELE
25 mental retardation, autosomal dominant 45 11.0 APOE LDLR LPA
26 hypercholesterolemia, due to ligand-defective apo b 11.0 APOE LDLR
27 delta-1-pyrroline-5-carboxylate dehydrogenase deficiency 11.0 APOE HMGCR LDLR
28 vascular disease 11.0
29 stone in bladder diverticulum 11.0 APOE LDLR LPA
30 perineurioma 11.0 ICAM1 SELE VEGFA
31 hyperaldosteronism 11.0 CCL2 ICAM1 VEGFA
32 lymphomatous thyroiditis 11.0 ICAM1 SELE VCAM1
33 progressive black carbon hyperpigmentation of infancy 11.0 EDN1 NOS3
34 hypertriglyceridemia 11.0
35 diffuse dermal angiomatosis 11.0
36 marginal corneal ulcer 11.0 ICAM1 SELE VCAM1
37 neonatal diabetes mellitus 11.0 CCL2 EDN1 SELE
38 autoimmune polyglandular syndrome type 3 11.0 PPARG TNF VCAM1
39 cytomegalovirus retinitis 11.0 CCL2 ICAM1
40 mechanical entropion 11.0 APOE NOS3
41 inferolateral myocardial infarct 11.0 ICAM1 SELE VCAM1
42 hepatic lipase deficiency 11.0
43 carotid artery disease 11.0
44 uveitis 11.0 CCL2 ICAM1 TNF
45 pityriasis rosea 10.9 MMP9 TNF VEGFA
46 hemochromatosis, type 5 10.9 APOE HMGCR LDLR
47 fish-eye disease 10.9 APOC2 APOE LDLR LPA
48 carotid stenosis 10.9
49 lethal congenital contractural syndrome 2 10.9 EDN1 NOS3 VEGFA
50 craniopharyngioma 10.9 ICAM1 SELE VCAM1

Graphical network of the top 20 diseases related to Atherosclerosis:



Diseases related to Atherosclerosis

Symptoms & Phenotypes for Atherosclerosis

UMLS symptoms related to Atherosclerosis:


angina pectoris, chest pain, edema

GenomeRNAi Phenotypes related to Atherosclerosis according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased free cholesterol GR00340-A-2 9.1 HMGCR LDLR LIPC LPA ABCG8 APOE

MGI Mouse Phenotypes related to Atherosclerosis:

44 (show all 11)
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.31 APOE EDN1 ICAM1 LDLR MMP9 NOS3
2 homeostasis/metabolism MP:0005376 10.3 APOE EDN1 HMGCR ICAM1 LDLR LIPC
3 cellular MP:0005384 10.22 ABCG8 APOE ICAM1 LDLR MMP9 NOS3
4 growth/size/body region MP:0005378 10.18 VEGFA APOE EDN1 HMGCR ICAM1 LDLR
5 digestive/alimentary MP:0005381 10.11 ABCG8 APOE EDN1 ICAM1 LDLR MMP9
6 immune system MP:0005387 10.1 LDLR MMP9 NOS3 OLR1 PPARG SELE
7 endocrine/exocrine gland MP:0005379 10.09 APOE EDN1 ICAM1 LDLR LIPC NOS3
8 liver/biliary system MP:0005370 9.91 ABCG8 APOE HMGCR LDLR NOS3 PPARG
9 muscle MP:0005369 9.85 EDN1 ICAM1 LDLR MMP9 NOS3 OLR1
10 renal/urinary system MP:0005367 9.5 APOE EDN1 MMP9 NOS3 PPARG PTGIS
11 vision/eye MP:0005391 9.28 APOE ICAM1 LDLR MMP9 NOS3 PPARG

Drugs & Therapeutics for Atherosclerosis

Drugs for Atherosclerosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 745)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Olmesartan Approved, Investigational Phase 4,Phase 3,Phase 2 144689-24-7, 144689-63-4 158781 130881
2
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-78-2 2244
3
Enalapril Approved, Vet_approved Phase 4 75847-73-3 5362032 40466924
4
Enalaprilat Approved Phase 4 76420-72-9 6917719
5
Rimonabant Approved, Investigational Phase 4,Phase 3 168273-06-1, 158681-13-1 104850
6
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 79902-63-9 54454
7
Fluvastatin Approved Phase 4,Phase 3,Phase 2 93957-54-1 1548972
8
Paclitaxel Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 33069-62-4 36314
9
Pioglitazone Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 111025-46-8 4829
10
Zinc Approved Phase 4,Phase 3,Phase 2 7440-66-6 32051 23994
11
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
12
Adenosine Approved, Investigational Phase 4,Phase 2,Phase 3 58-61-7 60961
13
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 2 128794-94-5 5281078
14
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2 24280-93-1 446541
15
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Early Phase 1 50-28-2 5757
16
Progesterone Approved, Vet_approved Phase 4,Phase 3,Phase 2 57-83-0 5994
17
Cilostazol Approved Phase 4,Phase 3,Phase 2,Phase 1 73963-72-1 2754
18
Probucol Approved Phase 4,Phase 2 23288-49-5 4912
19
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
20
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
21
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
22
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
23
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
24
Methyltestosterone Approved Phase 4 58-18-4 6010
25
Testosterone Approved, Investigational Phase 4 58-22-0 6013
26
Etanercept Approved, Investigational Phase 4,Phase 2 185243-69-0
27
Ustekinumab Approved, Investigational Phase 4 815610-63-0
28
Cyproterone Acetate Approved, Investigational Phase 4 427-51-0
29
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
30
Metformin Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 657-24-9 14219 4091
31
Acarbose Approved, Investigational Phase 4,Phase 3 56180-94-0 441184
32
Chromium Approved Phase 4,Phase 3 7440-47-3 27668
33
Ezetimibe Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 163222-33-1 150311
34
Lopinavir Approved Phase 4 192725-17-0 92727
35
Ritonavir Approved, Investigational Phase 4 155213-67-5 392622
36
Bisoprolol Approved Phase 4 66722-44-9 2405
37
Candesartan Approved Phase 4,Phase 3 139481-59-7 2541
38
Diltiazem Approved Phase 4,Phase 3,Phase 1 42399-41-7 39186
39
Adalimumab Approved Phase 4,Phase 3 331731-18-1 16219006
40
Dimethyl fumarate Approved, Investigational Phase 4 624-49-7 5271565 637568
41
Saxagliptin Approved Phase 4,Phase 3 361442-04-8 11243969
42
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1 55142-85-3 5472
43
Bupivacaine Approved, Investigational Phase 4,Phase 2,Phase 3 2180-92-9, 38396-39-3 2474
44
Clonidine Approved Phase 4 4205-90-7 2803
45
Levobupivacaine Approved Phase 4 27262-47-1 92253
46
Morphine Approved, Investigational Phase 4 57-27-2 5288826
47
Nitric Oxide Approved Phase 4,Phase 2 10102-43-9 145068
48
Menthol Approved Phase 4,Phase 2,Phase 3 2216-51-5 16666
49
Nebivolol Approved, Investigational Phase 4,Phase 3 152520-56-4, 99200-09-6, 118457-14-0 71301
50
Losartan Approved Phase 4,Early Phase 1 114798-26-4 3961

Interventional clinical trials:

(show top 50) (show all 2556)

id Name Status NCT ID Phase Drugs
1 The Study of the Effects of Vitamin A on Immune System in Patients With Atherosclerosis Unknown status NCT00963222 Phase 4 vitamin A;placebo
2 Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT) Unknown status NCT02360956 Phase 4 Olmesartan medoxomil tablets;Antihypertensive medication (per doctor suggestion)
3 Homocysteine Lowering and Atherosclerosis Reduction Trial (HART) Unknown status NCT00217178 Phase 4 Vitamins: Folic acid, B6, B12
4 Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases. Unknown status NCT00734123 Phase 4 Simvastatin or Atorvastatin;Enalapril;Aspirin or clopidogrel;Rimonabant
5 Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume Unknown status NCT01382277 Phase 4 Rosuvastatin
6 Fluvastatin AmelIorates aTHerosclerosis Study Unknown status NCT01681199 Phase 4 Fluvastatin extended release tablet
7 Paclitaxel Eluting Stent or Exercise for Thigh Atherosclerosis Unknown status NCT02033135 Phase 4
8 The Effect of Vitamin A on Atherosclerosis Unknown status NCT01414972 Phase 4 Vitamin A;placebo
9 Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions Unknown status NCT00640744 Phase 4 Atorvastatin
10 The Effect of a Natural Polyphenolic Extract From Pomegrnate (POMX) on the Development of Atherosclerosis in Diabetic Patients Unknown status NCT00470808 Phase 4 POMx
11 The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques Unknown status NCT01773512 Phase 4 Rosuvastatin
12 Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients Unknown status NCT00155350 Phase 4 pioglitazone
13 Type 2 Diabetes Mellitus and Atherosclerosis Unknown status NCT01250340 Phase 4 Aspirin;Placebo
14 Comparison of Stenting Versus Best Medical Therapy for Treatment of Ostial Renal Artery Stenosis: a Trial in Patients With Advanced Atherosclerosis Unknown status NCT00711984 Phase 4
15 Does Rosuvastatin Delay Progression of Atherosclerosis in HIV Unknown status NCT01813357 Phase 4 Rosuvastatin
16 Effects of REnal Denervation for Resistant Hypertension on Exercise Diastolic Function and Regression of Atherosclerosis and the Evaluation of NEW Methods Predicting A successfuL Renal Sympathetic Denervation (RENEWAL-EXERCISE, -REGRESS, and -PREDICT Tria Unknown status NCT01918111 Phase 4 adenosine infusion treatment
17 Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients Unknown status NCT00247494 Phase 4 mycophenol mofetil (MMF, Cellcept®) 500 mg BID
18 Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT) Unknown status NCT00712049 Phase 4 simvastatin;Nicotinic Acid
19 Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH) Unknown status NCT00885872 Phase 4 Rosuvastatin (Crestor)
20 Kronos Early Estrogen Prevention Study (KEEPS) Unknown status NCT00154180 Phase 4 Conjugated equine estrogens 0.45 mg/day;Transdermal estradiol, 50 mcg/day;Micronized progesterone, 200 mg/day x 12 d/month;CEE , progesterone, estradiol patch or placebo for each;CEE, progesterone, transdermal patch or the placebo
21 To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Unknown status NCT02098460 Phase 4 Atorvastatin, Probucol, Cilostazol
22 The Effect of Dates on Plasma Lipids, Oxidative Stress and the Atherogenicity of Serum in Healthy Adults Unknown status NCT00750789 Phase 4
23 Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis Unknown status NCT00484965 Phase 4
24 Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease Unknown status NCT01653600 Phase 4
25 Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial Unknown status NCT00500279 Phase 4 Celecoxib
26 Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging Unknown status NCT00920101 Phase 4 Atorvastatin
27 Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents Unknown status NCT01073111 Phase 4
28 The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients Unknown status NCT00247507 Phase 4 acetylcysteine
29 Sleep Disordered Breathing in Transient Ischemic Attack (TIA)/Ischemic Stroke and Continuous Positive Airway Pressure (CPAP) Treatment Efficacy Unknown status NCT01097967 Phase 4
30 CYPRESS - CYPHER for Evaluating Sustained Safety Unknown status NCT00954707 Phase 4 Clopidogrel & Aspirin, Prasugrel & Aspirin;Placebo & Aspirin
31 Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc) Unknown status NCT00736463 Phase 4 Simvastatin;Atorvastatin 80 mg
32 Resuvastatin Treatment for Symptomatic Middle Cerebral Artery Stenosis Based on High-resolution Magnetic Resonance Imaging Unknown status NCT02041117 Phase 4 Rosuvastatin
33 Testosterone for Peripheral Vascular Disease Unknown status NCT00504712 Phase 4 Testosterone;0.9% saline
34 Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level Unknown status NCT00866229 Phase 4 Rosuvastatin;Simvastatin
35 Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis Unknown status NCT02144857 Phase 4 etanercept;ustekinumab;cyclosporine
36 PCOS, Therapy and Markers of Cardiovascular Risk Unknown status NCT01798875 Phase 4 oral metformin;oral contraceptive
37 Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease Unknown status NCT01038050 Phase 4 Ginkgo Biloba Extract (GBE)
38 Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial) Unknown status NCT00858676 Phase 4 acarbose
39 Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease Unknown status NCT00188188 Phase 4 quinipril
40 Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial Unknown status NCT00120978 Phase 4 Advair;Flovent
41 Far Infrared Therapy on Peripheral Artery Disease in Hemodialysis Patients Unknown status NCT01095549 Phase 4
42 Effects of DES Platforms on Markers of Endothelial Damage and Inflammation Unknown status NCT01489202 Phase 4
43 Atorvastatin Plus Ezetimibe on Coronary Plaque Progression Unknown status NCT01086020 Phase 4 atorvastatin;atorvastatin plus ezetimibe
44 RAltegravir Switch STudy: Effects on Endothelial Recovery Unknown status NCT01453933 Phase 4 raltegravir
45 Comparison of Vascular Remodeling Between Different Antianginal Medication Evaluated by Noninvasive ECG-gated Fundus Photographic Evaluation Unknown status NCT01162902 Phase 4 Diltiazem treated group;Bisoprolol treated group;Candesartan treated group
46 Assessment of Surface Coverage of Two Types of DES in Diabetes Mellitus and Non- Diabetes Mellitus Unknown status NCT01023919 Phase 4
47 Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT Unknown status NCT01021930 Phase 4
48 Rosuvastatin Effect on Telomere-telomerase System in ACS Unknown status NCT02299245 Phase 4 rosuvastatin
49 Effect of Rosuvastatin Therapy on HDL2 Level Unknown status NCT02593487 Phase 4 Rosuvastatin 10mg/d group;Rosuvastatin 20mg/d group
50 Curcumin for Type 2 Diabetic Patients Unknown status NCT01052597 Phase 4 curcumin

Search NIH Clinical Center for Atherosclerosis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: atherosclerosis

Genetic Tests for Atherosclerosis

Genetic tests related to Atherosclerosis:

id Genetic test Affiliating Genes
1 Atherosclerosis 29

Anatomical Context for Atherosclerosis

MalaCards organs/tissues related to Atherosclerosis:

39
Endothelial, Heart, Kidney, Bone, Monocytes, Testes, Bone Marrow
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Atherosclerosis:
id Tissue Anatomical CompartmentCell Relevance
1 Endothelium Arteries Arterial Endothelial Cells Affected by disease
2 Heart Coronary Capillary Plexus Affected by disease
3 Heart Coronary Vessels Affected by disease

Publications for Atherosclerosis

Articles related to Atherosclerosis:

(show top 50) (show all 5100)
id Title Authors Year
1
Carotid versus coronary atherosclerosis burdens in acute compared with chronic symptomatic coronary artery disease. ( 28520469 )
2017
2
A Protocol for Diagnosis and Management of Aortic Atherosclerosis in Cardiac Surgery Patients. ( 28852575 )
2017
3
CT derived body fat distribution and incident cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis. ( 28938406 )
2017
4
Exosomal lncRNA GAS5 regulates the apoptosis of macrophages and vascular endothelial cells in atherosclerosis. ( 28945793 )
2017
5
New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis. ( 28937652 )
2017
6
MicroRNA-9 Inhibits NLRP3 Inflammasome Activation in Human Atherosclerosis Inflammation Cell Models through the JAK1/STAT Signaling Pathway. ( 28334721 )
2017
7
Metalloproteinase-9 contributes to endothelial dysfunction in atherosclerosis via protease activated receptor-1. ( 28166283 )
2017
8
Refining Prediction of Atrial Fibrillation Risk in the General Population With Analysis of P-Wave Axis (from the Atherosclerosis Risk in Communities Study). ( 28941601 )
2017
9
Per os colchicine administration in cholesterol fed rabbits: Triglycerides lowering effects without affecting atherosclerosis progress. ( 28950870 )
2017
10
Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study. ( 28938960 )
2017
11
Hypoxia inducible factor as a therapeutic target for atherosclerosis. ( 28942242 )
2017
12
Response by Bondonno et al to Letter Regarding Article, "Association of Vegetable Nitrate Intake With Carotid Atherosclerosis and Ischemic Cerebrovascular Disease in Older Women". ( 28830974 )
2017
13
Crosstalk Between Enzyme Matrix Metalloproteinases 2 and 9 and Regulatory T Cell Immunity in the Global Burden of Atherosclerosis. ( 28500763 )
2017
14
Crural Index and extensive atherosclerosis of crural vessels are associated with long-term cardiovascular mortality in patients with symptomatic peripheral artery disease. ( 28763728 )
2017
15
Cortisol is associated with low frequency of interleukin 10-producing B cells in patients with atherosclerosis. ( 28436142 )
2017
16
Association between central sleep apnea and left ventricular structure: the Multi-Ethnic Study of Atherosclerosis. ( 28220556 )
2017
17
An Obesity Paradox: Increased Body Mass Index Is Associated with Decreased Aortic Atherosclerosis. ( 28593612 )
2017
18
Association between coronary atherosclerosis progression and in-stent neoatherosclerosis in patients with ST-elevation myocardial infarction at 5-years follow-up. ( 28943494 )
2017
19
Asialoglycoprotein receptors as important mediators of plasma lipids and atherosclerosis. ( 28092276 )
2017
20
Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study. ( 28939714 )
2017
21
Postprandial Clearance of Oxidized Low-Density Lipoprotein in Patients with Stroke Due to Atherosclerosis. ( 28089094 )
2017
22
Chitotriosidase enzyme activity: is this a possible chronic inflammation marker in children with common variable immunodeficiency and early atherosclerosis? ( 27705887 )
2017
23
Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPARI^-Dependent Monocyte Differentiation and Function. ( 28408371 )
2017
24
Carotid atherosclerosis and its relationship to coronary heart disease and stroke risk in patients with type 2 diabetes mellitus. ( 28953658 )
2017
25
A study of the association of acanthosis nigricans with subclinical atherosclerosis. ( 28164885 )
2017
26
Risk Factors for Severe Hypoglycemia in Black and White Adults With Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. ( 28928117 )
2017
27
Letter by Tsuda Regarding Article, "Association of Vegetable Nitrate Intake With Carotid Atherosclerosis and Ischemic Cerebrovascular Disease in Older Women". ( 28830972 )
2017
28
Nuclear Factor (Erythroid-Derived 2)-Like 2 and Thioredoxin-1 in Atherosclerosis and Ischemia/Reperfusion Injury in the Heart. ( 27923281 )
2017
29
Diabetes, Prediabetes, and Brain Volumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). ( 28916531 )
2017
30
Flavonols reduce aortic atherosclerosis lesion area in apolipoprotein E deficient mice: A systematic review and meta-analysis. ( 28742839 )
2017
31
Paraoxonase and atherosclerosis-related cardiovascular diseases. ( 27771368 )
2017
32
Proteomic Study of Blood Serum in Coronary Atherosclerosis. ( 28091899 )
2017
33
High Resting Heart Rate and High BMI Predicted Severe Coronary Atherosclerosis Burden in Patients With Stable Angina Pectoris by SYNTAX Score. ( 28635302 )
2017
34
Elevated Plasma miR-29a Levels Are Associated with Increased Carotid Intima-Media Thickness in Atherosclerosis Patients. ( 28250354 )
2017
35
Rapidly progressive atherosclerosis after domino liver transplantation from a teenage donor with homozygous familial hypercholesterolemia. ( 28807459 )
2017
36
GSTM1 polymorphism in patients with clinical manifestations of atherosclerosis. ( 28362975 )
2017
37
Aspirin-triggered lipoxin inhibits atherosclerosis progression in ApoE(-/-) mice. ( 28071789 )
2017
38
Endosialin Promotes Atherosclerosis Through Phenotypic Remodeling of Vascular Smooth Muscle Cells. ( 28126825 )
2017
39
Association of ADIPOQ single nucleotide polymorphisms with the risk of intracranial atherosclerosis. ( 27224208 )
2017
40
Dietary intake and peripheral arterial disease incidence in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. ( 28077376 )
2017
41
Vascular CXCR4 Limits Atherosclerosis by Maintaining Arterial Integrity: Evidence From Mouse and Human Studies. ( 28450349 )
2017
42
C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus. ( 28218562 )
2017
43
Variability of Methylation Profiles of CpG Sites in microrNA Genes in Leukocytes and Vascular Tissues of Patients with Atherosclerosis. ( 28601079 )
2017
44
Plasma Soluble Endoglin Levels Are Inversely Associated With the Severity of Coronary Atherosclerosis-Brief Report. ( 27789477 )
2017
45
Association between endothelial dysfunction, epicardial fat and sub-clinical atherosclerosis during menopause. ( 28939053 )
2017
46
CD4(+)CD28(null) T Cells are related to previous cytomegalovirus infection but not to accelerated atherosclerosis in ANCA-associated vasculitis. ( 28084533 )
2017
47
Socioeconomic Status and Incidence of Hospitalization With Lower-Extremity Peripheral Artery Disease: Atherosclerosis Risk in Communities Study. ( 28862929 )
2017
48
Increased Levels of Oxidative Stress Markers, Soluble CD40 Ligand, and Carotid Intima-Media Thickness Reflect Acceleration of Atherosclerosis in Male Patients with Ankylosing Spondylitis in Active Phase and without the Classical Cardiovascular Risk Factors. ( 28883908 )
2017
49
microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis. ( 28428217 )
2017
50
Atherosclerosis of aberrant arteries from the left gastric artery into the right intralobar pulmonary sequestration complicated by mycobacterial epithelioid cell granuloma. ( 27776258 )
2017

Variations for Atherosclerosis

Copy number variations for Atherosclerosis from CNVD:

7
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 207754 6 160900000 164400000 Gain LPA Atherosclerosis